cancer services

Cancer Health Risk Assessment

Take a Health Risk Assessment

Our risk assessment takes about 5-7 minutes to complete. At the end you will receive a free personalized risk assessment report that will help you:

  • Identify risk factors that may increase your chance of developing breast cancer
  • Understand healthy lifestyle choices you can take to reduce your risk
  • Learn facts and tips to manage your health based on the information provided in the assessment

Then when you are ready request an appointment online.

Take an assessment

Breast cancer

Excluding cancers of the skin, breast cancer is the most common cancer among women, accounting for nearly 1 in 3 cancers diagnosed in US women. Men are generally at low risk for developing breast cancer; however, approximately 1% of the male population will develop breast cancer.

Take the Breast Cancer Assessment

Colorectal cancer

Colorectal cancer is the third leading cause of cancer deaths in women and second leading cause of cancer deaths in men in the U.S. The good news is that the five-year survival rate for colorectal cancer if found early is 90%. That’s why understanding your risk factors for developing colon cancer is so important.

Take the Colorectal Cancer Assessment

Lung cancer

According to the American Cancer Society, lung cancer is the leading cause of cancer death among both men and women, making up almost 25% of all cancer deaths. Not all cases of lung cancer can be prevented, but there are some ways you can reduce your risk of getting lung cancer.

Take the Lung Cancer Assessment

Prostate cancer

The prostate is a gland located in front of the rectum and underneath the urinary bladder. It is found only in men. The size of the prostate varies with age. In younger men, it is the size of a walnut, but it can be much larger in older men. Several types of cells are found in the prostate, but almost all of prostate cancers develop from the gland cells. The medical term for a cancer that starts in gland cells is adenocarcinoma.

Take the Prostate Cancer Assessment